We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

Q:NYSEQnity Electronics, Inc. Analysis

Data as of 2026-03-11 - not real-time

$113.97

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Qnity Electronics is trading below its 20‑day moving average but above its longer‑term averages, indicating a short‑term pullback within a broader bullish trend. The stock recently posted a strong earnings beat, with adjusted Q4 EPS surpassing expectations, and volume has been on the rise, supporting the upside momentum. Technical signals are mixed: RSI hovers near the midpoint, while MACD shows a bearish divergence, suggesting caution ahead of the next move toward the $140 resistance. The company carries a high beta and 30‑day volatility above 50%, reflecting sensitivity to market swings, and its balance sheet is leveraged with debt exceeding cash, adding financial risk. Despite these headwinds, the dividend payout is minimal and well‑covered, and analysts collectively rate the stock as a strong buy with a median target of $140, implying notable upside potential.
Overall, the blend of solid earnings momentum, sector tailwinds from AI‑driven semiconductor demand, and a supportive analyst consensus outweighs the valuation premium indicated by the DCF model, making Q a compelling candidate for investors comfortable with higher volatility and leverage.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Recent earnings beat and rising volume
  • Price near established support level
  • Mixed technical signals (bearish MACD, neutral RSI)

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus strong‑buy with median target above current price
  • Secular growth in semiconductor and AI data‑center demand
  • Sustainable dividend despite low yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term industry tailwinds for specialty semiconductor materials
  • Strategic positioning after spin‑off with focused product portfolio
  • Potential for earnings expansion outweighing current leverage concerns

Key Metrics & Analysis

Financial Health

Revenue Growth8.10%
Profit Margin14.56%
P/E Ratio34.4
ROE7.98%
ROA4.84%
Debt/Equity61.43
P/B Ratio3.4
Op. Cash Flow$1.3B
Free Cash Flow$776.5M
Industry P/E36.8

Technical Analysis

TrendBullish
RSI52.9
Support$106.00
Resistance$140.60
MA 20$115.59
MA 50$102.34
MA 200$94.47
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair Value$55.50
Target Price$140.22
Upside/Downside23.03%
GradeFair
TypeBlend
Dividend Yield0.12%

Risk Assessment

Beta2.84
Volatility59.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.